Lindera aggregata -derived Extracellular Vesicles Target Inflammation for Alleviating IBD associated psychiatric disorders via Microbiota-Gut-Brain Axis
Abstract Background The imbalance in the gut-brain is strongly associated with psychiatric conditions related to inflammatory bowel disease (IBD), and an effective treatment approach has not been established. Current oral treatments are limited due to the spatial and functional divide between gut inflammation and central nervous system (CNS) issues. Purpose The purpose of this research was to investigate the therapeutic impact of extracellular vesicles derived from Lindera aggregate leaf (LALEVs) and root (LAREVs) in alleviating DSS-induced intestinal damage and behavioral disorders in mice. Methods Dextran sulfate sodium (DSS) was used to establish an acute ulcerative colitis (UC) mouse model, and the mice were administered LALEVs and LAREVs orally. After the oral intervention, comprehensive assessments were performed utilizing pathological, biochemical, and molecular biological approaches, alongside 16S rRNA sequencing and behavioral evaluations, to examine intestinal barrier integrity, gut microbiome composition, lipopolysaccharide (LPS) levels, and pro-inflammatory cytokine production. Behavioral assessments were conducted to assess anxiety-, depressive-like behaviors, and cognitive impairment, while neuroinflammatory responses were evaluated by monitoring microglial and astrocytic activation, neuronal injury, and neuroinflammation. Potential targets were explored by serum proteomics, Gene Set Enrichment Analysis (GSEA), and network pharmacology, and verified by western blot. Results Oral administration of LALEVs or LAREVs targeted inflamed colon, effectively restoring the compromised barrier. Colon length normalized, weight loss ceased, and inflammatory cytokines (TNF-α, IL-6, and IL-1β) were quieted. Behavioral tests indicated marked improvements in spontaneous activity and a substantial reduction in anxiety, depression-like behaviors, and cognitive impairment. Through by microbiota-gut-brain axis, LALEVs and LAREVs prevent LPS and inflammatory factors from entering the blood and suppress microglial and astrocyte activation in brain through modulating of TLR4/p38 MAPK axis, thereby reducing neuroinflammation and protecting against neural damage. Our work suggested that Lindera aggregate -derived extracellular vesicles could serve as a dual-target therapy for addressing IBD and psychiatric disorders.
Authors
- You‐Min Ying (ORCID: https://orcid.org/0000-0002-2231-5068)
- Aibo Xu (ORCID: https://orcid.org/0000-0001-5612-0720)
- Qian Tong (ORCID: https://orcid.org/0009-0005-6015-6298)
- Kai Yu (ORCID: https://orcid.org/0000-0003-3343-2902)
- Ke Hao (ORCID: https://orcid.org/0000-0002-8013-9277)
- Xiaoting Zhang
- Chengwen He
- Zhen Wang
- Jigeng Cao
- Kaiqiang Li
- Wei Xu
- Tingting Hu
- Kaixuan Li
Institutions
- Zhejiang Chinese Medical University (CN)
- Fudan University (CN)
- Zhejiang Provincial People's Hospital (CN)
- Hangzhou Medical College (CN)
- Zhejiang University of Technology (CN)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-13
- DOI
- https://doi.org/10.21203/rs.3.rs-11305681/v1
- Primary Topic
- Inflammatory Bowel Disease
- Type
- preprint
Funders
- National Natural Science Foundation of China